BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3493566)

  • 1. Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.
    Davis JE; Cook RG; Brown MF; Pollack MS; Van M; Rich RR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):851-7. PubMed ID: 3493566
    [No Abstract]   [Full Text] [Related]  

  • 2. Late-onset form of congenital adrenal hyperplasia in the HLA-B14; DR1 haplotype is caused by a duplication in the 21-OH MHC gene region.
    Boehm BO; Rosak C; Kuehnl P; Schöffling K
    Horm Metab Res; 1986 Nov; 18(11):791-2. PubMed ID: 3491779
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1.
    Speiser PW; New MI; White PC
    N Engl J Med; 1988 Jul; 319(1):19-23. PubMed ID: 3260007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating HLA-DR bearing T cells: correlation with genetic rather than clinical variables.
    Clegg DO; Pincus SH; Zone JJ; Ward JR
    J Rheumatol; 1986 Oct; 13(5):870-4. PubMed ID: 3493345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family with an apparent HLA-DR triplet: evidence for exchange of functional HLA-DR beta-genes between different haplotypes.
    Tilanus MG; van Eggermond MC; Fei HM; Schreuder GM; Giphart MJ
    Exp Clin Immunogenet; 1989; 6(2):162-8. PubMed ID: 2576521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of an immune response gene effect by point mutation in the antigen sequence.
    Lechler RI; Bal V; Ikeda H; Trowsdale J; Rothberd JB; Lamb JB
    Transplant Proc; 1989 Feb; 21(1 Pt 1):618-20. PubMed ID: 2495624
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-DR (HLA) linkage imbalance and transplants in Chile: a preliminary report].
    Valenzuela C; Elgueta S; Thambo S; Avendaño P; Cotera A; Fuentes C; Santa Maria L; Wegmann ME; Neira L
    Rev Med Chil; 1990 May; 118(5):500-2. PubMed ID: 2293268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antiviral T-cell clone defines a functional supertypic specificity shared by different HLA-DR molecules from DR2-short, DRw11, and DRw13 haplotypes.
    Zeliszewski D; Sterkers G; Choppin J; Freidel C; Gebuhrer L; Betuel H; Levy JP
    Immunogenetics; 1987; 25(2):84-90. PubMed ID: 3493215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New evidence for the existence of HLA-B14 subtypes. Linkage with different DR antigens.
    Mueller-Eckhardt G; Mayr WR; Prel L; Mueller-Eckhardt C
    Tissue Antigens; 1983 Jan; 21(1):58-61. PubMed ID: 6404003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute lymphoblastic and nonlymphoblastic leukemia in 1st complete remission: consolidation treatment by intensive radio-chemotherapy followed by transplantation of HLA-A, B and Dr compatible allogeneic bone marrow].
    Gyger M; Perreault C; Bonny Y; Bélanger R; David M; Boileau J; Tawil E; Lavallée R; Lacombe M; d'Angelo G
    Union Med Can; 1986 Oct; 115(10):699-702. PubMed ID: 3541340
    [No Abstract]   [Full Text] [Related]  

  • 13. Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.
    Rosen-Bronson S; Johnson AH; Hartzman RJ; Eckels DD
    Immunogenetics; 1986; 24(5):286-97. PubMed ID: 3491043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of hybrid DQ molecules by the use of T cell clone and 2D-gel analyses].
    Hawkin S
    Hokkaido Igaku Zasshi; 1986 Nov; 61(6):892-901. PubMed ID: 3493964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens in 88 cases of rheumatic fever observed in Martinique.
    Monplaisir N; Valette I; Bach JF
    Tissue Antigens; 1986 Oct; 28(4):209-13. PubMed ID: 3492779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic study of a family of subjects with ankylosing spondylitis].
    Deshayes P; Demangeon S; Cavelier B; Le Loët X; Daragon A; Ropartz C
    Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):171-4. PubMed ID: 3495859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
    Wyatt RJ; Julian BA; Woodford SY; McLean RH; Thompson JS
    Semin Nephrol; 1987 Dec; 7(4):389-92. PubMed ID: 3502194
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-DQ molecular heterogeneity in HLA-DR4-Dw4 consanguineous cell lines.
    Fernandez N; Labeta M; Kurpisz M; Solana R; Festenstein H
    Dis Markers; 1986 Jun; 4(1-2):191-8. PubMed ID: 3502560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
    Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
    Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
    Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
    Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.